Special considerations for treatment of type 2 diabetes mellitus in the elderly
- Diabetes is poorly controlled in a majority of elderly people. // Clinical Advisor;Sep2015, Vol. 18 Issue 9, p24
No abstract available.
- Intensive dietary advice significantly improves HbA(1c) in patients with type II diabetes who remain hyperglycaemic despite optimised drug treatment. Wexler, Deborah J; Grant, Richard W // Evidence Based Medicine;Dec2010, Vol. 15 Issue 6, p179
A review is presented of the article "Nutritional Intervention in Patients With Type 2 Diabetes Who are Hyperglycaemic Despite Optimised Drug Treatmentâ€“Lifestyle Over and Above Drugs in Diabetes (LOADD) Study: Randomised Controlled Trial" by K. J. Coppell et al., which appeared in a 2010...
- I was recently diagnosed with type 2 diabetes and am getting used to doing daily blood sugar tests and logging my results. Why does my doctor want to do a blood sugar test called A1C every few months, too? // Mayo Clinic Health Letter;Oct2012, Vol. 30 Issue 10, p8
The article presents questions and answers pertaining to the need of undergoing A1C blood test after being diagnosed with type 2 diabetes.
- Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes. Richard III, John W.; Raskin, Philip // Clinical Medicine Insights: Endocrinology & Diabetes;2011, Issue 4, p29
As the prevalence of type 2 diabetes continues to rise, new drug therapies will need to be explored to prevent morbidity and mortality associated with diabetes as well as growing health care costs. Type 2 diabetes is characterized by decreased insulin secretion and sensitivity. Numerous oral...
- News focus--The benefits of lower HbA1c targets. Moberly, Tom // Independent Nurse;5/14/2010, p1
The article reports that re-analysis of data from the 2008 ACCORD study indicates that lower glycated haemoglobin (HbA1c) levels are associated with a lower risk of mortality, and are not the cause of the raised mortality in the study group as previously believed. However, experts caution that...
- Sitagliptin/metformin fixed-dose combination: a guide to its use in type 2 diabetes mellitus. // Drugs & Therapy Perspectives;Sep2011, Vol. 27 Issue 9, p1
Sitagliptin/metformin is an effective and well tolerated option in the treatment of type 2 diabetes mellitus. In clinical trials in patients with type 2 diabetes, combination therapy with sitagliptin plus metformin improved glycaemic control, including in patients inadequately controlled with...
- Observational Study of Once-Daily Insulin Detemir in People with Type 2 Diabetes Aged 75 Years or Older. Karnieli, Eddy; Baeres, Florian; Dzida, Grzegorz; Ji, Qiuhe; Ligthelm, Robert; Ross, Stuart; Svendsen, Anne; Yale, Jean-François // Drugs & Aging;2013, Vol. 30 Issue 3, p167
Objectives: Older patients are particularly vulnerable to hypoglycaemia. The aim of this study was to evaluate the response to initiation of once-daily insulin detemir in patients aged â‰¥75 years with type 2 diabetes mellitus (T2DM) treated with one or more oral antidiabetic drugs (OADs)....
- Frailty and hypoglycaemia in older people with type 2 diabetes: Therapeutic implications. Abdelhafiz, Ahmed; Luan Koay; Sinclair, Alan // Journal of Diabetes Nursing;2016, Vol. 20 Issue 9, p330
No abstract available.
- Weighing the Potential Benefits and Risks of Antidiabetic Agents in Older Adults. Neumiller, Joshua J.; Soule Odegard, Peggy; Haines, Stuart T. // Diabetes Spectrum;Summer2012, Vol. 25 Issue 3, p172
The article presents the case study of an 81-year-old woman who presented to the emergency department (ED) after a fall in her kitchen and was subsequently hospitalized with a hip fracture due to a hypoglycemia event. She was told to discontinue glyburide, referred to a dietitian for education...